宜昌招聘

Novo Nordisk is a focused healthcare company and a world leader in diabetes care. Novo Nordisk Research Center China (NNRCC) is an integrated part of Novo Nordisk R&D organization. Novo Nordisk wants to conduct diabetes research activities in China and expand its network to the scientific community. For these purposes, a new position is open for a highly qualified and motivated scientist/manager with expertise within diabetes/obesity/diabetic complication biology who plans to advance a career in China.

Diabetes Research China (DRC) is part of NNRCC located in Beijing. DRC is responsible for support of diabetes, obesity and diabetic complication research projects in the discovery phase. Currently, DRC is composed of four departments, Diabetes Protein Engineering, Diabetes Biology and Pharmacology, Histology, and Pharmacology & Facility. Diabetes Biology and Pharmacology contains two teams, Team Biology and Team Rodent Pharmacology. Altogether, we are a highly motivated and productive team with high standards for our deliveries into the projects. We work with state-of-the-art facilities and equipment and value a high team spirit, good communication and dynamic collaboration both internally and with external colleagues. DRC is expected to grow significantly over the next years, which leads to excellent opportunities for individual development

Main Tasks:
Take responsibility in further developing the rodent pharmacology at Novo Nordisk Diabetes Research China. You will plan and conduct in vivo studies, set-up and develop models, and evaluate the translational value of such models within the area of diabetes complication especially diabetic nephropathy. Our center is growing rapidly and you will be expected to impact the development of our expertise area and represent it in the projects. Furthermore, you will be expected to leverage the innovation culture, mentor colleagues, and promote the collaboration culture both internally and globally.

You will be involved in cross-functional project teams with colleagues from many different scientific backgrounds both in China and in Denmark. You will be a key person in research projects and responsible for defining the direction of the in vivo pharmacology and/or ex vivo biology in the project. You will be the department representative in research projects where you are expected to seek influence based on the data you generate and by keeping up to date with the scientific literature.

You will be referring directly to the Team Leader and your main internal contacts in your daily work will be scientist colleagues, research associates, project members, and managers both in Beijing and in Denmark. Furthermore, developing and maintaining a strong external network is also going to be an important part of your work.

You will be part of a team in a highly dynamic and challenging environment within the Novo Nordisk Diabetes Research Unit.
Qualifications:
·Ph.D. within biological sciences.
·Excellent scientific background with proved expertise in diabetic retinopathy.
·Minimum 3 years working experience with in vivo pharmacology within diabetic retinopathy biology. Industry experience is preferred but not required. CRO interaction experience is a plus.

You need to have good communication and collaboration skills as you will play a key role in representing your expertise area in global project teams and towards colleagues at the other research sites. You are flexible, open to new ideas, ambitious, innovative and result oriented. You have a lot of individual responsibility with a high degree of personal impact in the projects. You are able to meet deadlines and keep overview. Furthermore, you are fluent in English.

Title and compensation will be commensurate with the applicant’s qualifications and based on benchmark in China.

For submission of application please send cover letter and resume with position title in the subject of email to Fang Zhang: fazn@novonordisk.com

　　诺和诺德是世界领先的生物制药公司，在用于糖尿病治疗的胰岛素开发和生产方面居世界领先地位。诺和诺德总部位于丹麦首都哥本哈根，员工总数30000人，分布于79个国家，产品销售遍布180个国家。在欧美均建有生产厂。
　　诺和诺德的产品60年代初就已进入中国市场。1994年初，诺和诺德董事会通过了在中国实施战略投资的计划，在北京建立诺和诺德（中国）制药有限公司总部和生物技术研究发展中心，在天津兴建现代化生产工厂，并在全国30多个城市建立了完善的营销体系。欲了解详情，请访问诺和诺德中国网站：www.novonordisk.com.cn

　　为配合公司在中国业务的迅速发展，现诚聘。

　　诺和诺德将为您提供具有竞争力的福利、完善的个人发展与培训机会，使您在国际化的管理与富有挑战性的工作环境中不断地进步与自我实现！应聘者请将个人简历、期望薪水、身份证、学历证明复印件于10日内寄至本公司。
　　请在信封上注明应聘职位。